Elisa ten Hacken (@etenhacken) header
Elisa ten Hacken (@etenhacken) profile picture

Assistant Professor @WeillCornell NYC | Interested in disease modeling & mechanistic biology | Tweets are my own

Manhattan, NY
Joined August 2014
Photo by Elisa ten Hacken (@etenhacken)Photo by Elisa ten Hacken (@etenhacken)Photo by Elisa ten Hacken (@etenhacken)Photo by Elisa ten Hacken (@etenhacken)Photo by Elisa ten Hacken (@etenhacken)Photo by Elisa ten Hacken (@etenhacken)Photo by Elisa ten Hacken (@etenhacken)Photo by Elisa ten Hacken (@etenhacken)Photo by Elisa ten Hacken (@etenhacken)Photo by Elisa ten Hacken (@etenhacken)
#AndJustLikeThat 🌟the ten Hacken lab is officially live from @WeillCornell NYC! 🌟 Join me in this new exciting adventure if you are interested in understanding chronic lymphocytic leukemia and Richter’s syndrome through mouse modeling (and more!). Recruiting at all levels!
16
5
2
103
17,353
Elisa ten Hacken retweeted
How does SF3B1 mutation rewires signaling to drive aggressive CLL—check this out in our lab’s work out today @JCI_insight Congrats to first authors Bo Zhang, @PrajishIyer, Meiling Jin, @etenhacken!
Could targeting RNA splicing represent an alternative strategy in chronic lymphocytic leukemia? @PrajishIyer @LiliWangLab @cityofhope find mutation in the RNA splicing factor SF3B1 activates the mTOR pathway to contribute to aggressive #CLL. See full report: insight.jci.org/articles/vie… The figure shows spleens from mice with 13q deletion in murine B cells (Mdr) in addition to Sf3b1-K700E (DM) leads to aggressive CLL, indicated by hyperproliferative markers.
4
1
10
1,803
Elisa ten Hacken retweeted
ASH is committing more than $12 million to address research funding challenges and support the next generation of hematologists. Learn more: ow.ly/sK3050W735W #Fight4Hematology
2
31
4
77
12,598
Elisa ten Hacken retweeted
International Consensus Statement on Diagnosis, Evaluation, and Research of Richter Transformation: the ERIC Recommendations ashpublications.org/blood/ar…
4
11
42
3,552
Being a PI is a very challenging journey, witnessing progress and excitement in your mentees the most rewarding. Happy 2nd birthday to the ten Hacken lab!
8
2
199
15,176
Elisa ten Hacken retweeted
Thanks to the generous support of @EHA_Hematology we have two travel awards for early career researchers working in Europe to attend the 2025 FASEB Hematologic Malignancies Meeting!!! Please share! (Link in comments)
1
5
13
2,135
Elisa ten Hacken retweeted
2️⃣ Gain expert insights on optimizing therapeutic strategies across multiple lines of therapy. 3️⃣ Explore the future of #CLL treatment with cutting-edge immunological and non-immunological approaches.
1
1
330
🚨📣The Blood Art Contest winner has been selected! 🎉Congratulations to Alan G. Ramsay and co-authors! @ramsaylab @kingscollegelon ow.ly/f1UJ50UZig7 #bloodjournals
4
1
9
3,478
Recently published: Addressing Health Disparities in Hematologic Malignancies: from Genes to Outreach brnw.ch/21wQttA
6
15
1,727
Thankful to @ASH_hematology for continued support! Join my group if you are interested in functional genomics of Richter Transformation! hematology.org/newsroom/pres…
3
344
I just committed to ride my 15th consecutive Pan-Mass Challenge bike ride on Aug 2/3 to support our CLL and lymphoma research @DanaFarber. Click here to support my ride! #CloserByTheMile donate.pmc.org/MD0305 #PMC2025 via @panmass
1
3
21
1,407
On my way to #ASH24! Excited to present some of our recent work at tomorrow’s 641 CLL session. Come join the discussion!
2
16
580
Elisa ten Hacken retweeted
🚨MRC-iCASE PhD studentship available🚨to join my lab at @KingsCollegeLon and study lymph node stroma-immune interactions in lung cancer to improve immunotherapy. 🗓️Closing date Tue 29 October 1PM @KCL_MRCDTP #MRCDTP25 #PhDposition #London #AstraZeneca tinyurl.com/44s9upep
2
8
20
1,639
It’s a wrap #ERIC2024! Thanks for the opportunity to share my perspective on CLL and RT mouse modeling in beautiful Barcelona!
14
712
Elisa ten Hacken retweeted
Thrilled to share we are @theNCI R00-funded. 🥳 Looking for computational biologists or bioinformaticians. 👩‍💻👨‍💻 We have many exciting projects on the role of chromatin remodelers in blood cancers. 🩸🦀 Please share/DM/email if relevant. Our latest story: cell.com/cancer-cell/abstrac…
10
10
3
47
9,124
We are hard at work to improve our knowledge of a critical complication of CLL named Richter’s syndrome. Join my team if you are interested in exploring functional genomics in mouse models and more! Positions are open for both experimental and computational postdocs!
Today is World CLL Day 2024! Let’s raise awareness and advocate for equal care and treatment opportunities for Chronic Lymphocytic Leukemia (#CLL) patients worldwide. Your support can make a difference and ensure that CLL receives the resources and/or recognition it deserves alongside other cancers. 👉 Learn more and get involved at wclld.org #LetsLevelUp #WCLLD24
1
481
Congrats @LCerchietti for this fantastic achievement!
A new $12.5 million @NIH grant for lymphoma research is the result of a team collaboration led by Dr. Leandro Cerchietti (@LCerchietti) in our #HemOnc division & Dr. Christopher Flowers of @MDAndersonNews bit.ly/3YRARge. @WCM_MeyerCancer @WCMLymphoma @WeillCornell
3
361
Elisa ten Hacken retweeted
Excited to share our latest publication from the Lili Wang lab! by Prajish Iyer et al.🌟 MGA deletion drives Richter’s transformation by modulating mitochondrial OXPHOS, highlighting new therapeutic avenues. @DanilovLab @CllSociety science.org/doi/10.1126/scit…
1
5
17
930